Novel Diagnosis of Ectopic Pregnancy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorAcibadem University
About this trial
In the project, the investigators aim to determine the Beta- human chorionic gonadotropin (BHCG) value with serial measurements on the same day in the diagnosis of ectopic pregnancy.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Positive bhcg levels
Disqualifiers
clinically diagnosis of intrauterine pregnancy
Trial design
Design model
Parallel
Treatments tested in this trial
serum BHCG testing
Diagnostic testTaking 5ml blood samples every 2 hours for 5 times for measurement of BHCG. Blood samples will be taken from the median cubital and cephalic veins which is located inner side of the elbow.
Treatment groups
20 Participants
are divided into 2 treatment groupsGroup A: ectopic pregnancy patientsExperimental treatment 1 intervention
Group B: Normal pregnancyActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Changes in Beta-hCG Levels Measured Every 2 Hours as a Discriminating Factor Between Ectopic and Normal Pregnancy
The primary outcome is how the changes in Beta-hCG levels measured every two hours differ between the ectopic pregnancy and the normal pregnancy.
Time frame
10 hoursSecondary outcomes
1
Increase pattern of BHCG levels in normal pregnancy
BHCG increase pattern every two hours in normal pregnancy
Time frame
10 hoursLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: